New research: Out of thousands, only 42 people started long-acting injectable PrEP

Far fewer people than expected began taking injectable PrEP in the first few years since its approval. A recent article in JAIDS explores--what's going on?

And will I like the energy they bring?

From once-yearly injectable PrEP to new HIV meds requiring less frequent dosing, Liz Highleyman summarizes in-progress HIV and PrEP research.

There are resources in San Francisco and beyond that can help–whether you’re looking for PrEP coverage, HIV treatment, basic medical care, trans care, or other types of care.

Prominent trans activists share their candid reflections on the current state of trans rights, the scramble for access to life-saving healthcare, and how they're finding hope despite mounting political threats.

Información imprescindible para personas que viven con VIH, personas que toman PrEP y/o personas inmigrantes sobre los cambios en la cobertura de seguros y programas que pueden ofrecer asistencia.

In a phase 3 study, people living with HIV were able to successfully switch from complex regimens to a once-daily tablet.

With LGBTQ rights under threat, it’s never too early to make legal arrangements–especially if your family may disagree with your wishes.